The Selective Targeting of Unique Metabolic Properties of Leukemic Stem Cells in Acute Myeloid Leukemia
DOI:
https://doi.org/10.15173/sciential.vi6.2723Keywords:
acute myeloid leukemia, leukemic stem cells, cancer stem cells, stem cell metabolism, cancer relapseAbstract
Current therapeutic options in the treatment of acute myeloid leukemia often succumb to high instances of relapse and subsequent mortality. Chemotherapy and radiotherapy have long been used as the standard treatment for this disease, remaining stagnant over the past few decades. Recently, a small self-renewing population of leukemic stem cells have been identified as drivers of cancer relapse and progression due to their increased resistance to anticancer therapeutics. This enables these cells to maintain a minimal residual disease and results in downstream differentiation, leading to relapse. Targeting these cells may lead to effective therapies that reduce relapse and mortality. Recently, the metabolic properties of leukemic stem cells have begun to be elucidated. Here, we discuss recent discoveries regarding the metabolism of leukemic stem cells and approaches to targeting their unique metabolic properties.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Sciential - McMaster Undergraduate Science Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors submitting to the journal must adhere to the terms of Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license as outlined below:
1. You are free to share (copy and redistribute) any material from this journal, granted you have given appropriate credit, provided the link to the license, and indicated whether changes were applied to original work.
2. You are free to adapt (remix, transform, and build upon) any material from this journal, granted you distribute your work under the same license.